Tapewire

Nasdaq · USD

NTRA

Natera, Inc.

Export transactions ↓
Tapewire entity
2635
SEC CIK
0001604821
Parsed reports
1,197

Last 12 months

Inside the activity.

0 purchase rows · 457 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025047
Dec 2025021
Jan 2026041
Feb 2026021
Mar 2026054
Apr 2026029
May 2026033
Jun 2026068
Jul 2026047
Aug 2026033
Sep 2026059
Oct 202604

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 23, 2024 Filed May 25, 2024 01:05 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 264 $107.77 $28,449.96
Disclosure

SEC source: 0001415889-24-014600 · form4-05242024_090501.xml · nonDerivative · entry 3

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Indirect · By Caraluna 2 Trust

Disclosed balance after: 68,818

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.39 to $108.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.

Read SEC document
May 23, 2024 Filed May 25, 2024 01:05 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 156 $109.16 $17,028.74
Disclosure

SEC source: 0001415889-24-014600 · form4-05242024_090501.xml · nonDerivative · entry 2

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Indirect · By Caraluna 1 Trust

Disclosed balance after: 68,582

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.79 to $109.20 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.

Read SEC document
May 23, 2024 Filed May 25, 2024 01:05 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 344 $107.90 $37,118.12
Disclosure

SEC source: 0001415889-24-014600 · form4-05242024_090501.xml · nonDerivative · entry 1

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Indirect · By Caraluna 1 Trust

Disclosed balance after: 68,738

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.40 to $108.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.

Read SEC document
May 16, 2024 Filed May 18, 2024 01:35 UTC
Sheena JonathanDirector · CO-FOUNDER
GiftCommon Stock 11,853 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-013651 · form4-05172024_090505.xml · nonDerivative · entry 1

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 307,208

F1 · shares: Reflects the transfer of shares as a bona fide gift to a charitable foundation.

Read SEC document
May 15, 2024 Filed May 18, 2024 01:35 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
SaleCommon Stock 3,320 $107.59 $357,201.12
Disclosure

SEC source: 0001415889-24-013650 · form4-05172024_090501.xml · nonDerivative · entry 2

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 219,456

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.2920 to $108.02 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 15, 2024 Filed May 18, 2024 01:35 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
SaleCommon Stock 3,459 $106.59 $368,710.03
Disclosure

SEC source: 0001415889-24-013650 · form4-05172024_090501.xml · nonDerivative · entry 1

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 222,776

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.10 to $107.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 10, 2024 Filed May 11, 2024 01:35 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $19.68 $0.00
Disclosure

SEC source: 0001415889-24-012937 · form4-05102024_090508.xml · derivative · entry 6

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 30,000 shares

Expires 2029-03-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option shares are fully exercisable.

Read SEC document
May 10, 2024 Filed May 11, 2024 01:35 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
SaleCommon Stock 10,350 $108.10 $1,118,783.25
Disclosure

SEC source: 0001415889-24-012937 · form4-05102024_090508.xml · nonDerivative · entry 5

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 204,495

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.55 to $108.11 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 10, 2024 Filed May 11, 2024 01:35 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
SaleCommon Stock 4,255 $104.03 $442,633.61
Disclosure

SEC source: 0001415889-24-012937 · form4-05102024_090508.xml · nonDerivative · entry 4

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 214,845

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.85 to $104.77 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 10, 2024 Filed May 11, 2024 01:35 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
SaleCommon Stock 9,398 $102.91 $967,151.94
Disclosure

SEC source: 0001415889-24-012937 · form4-05102024_090508.xml · nonDerivative · entry 3

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 219,100

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.83 to $103.55 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 10, 2024 Filed May 11, 2024 01:35 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
SaleCommon Stock 5,997 $101.55 $608,998.35
Disclosure

SEC source: 0001415889-24-012937 · form4-05102024_090508.xml · nonDerivative · entry 2

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 228,498

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.30 to $102.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 10, 2024 Filed May 11, 2024 01:35 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
Exercise / conversionCommon Stock 30,000 $19.68 $590,400.00
Disclosure

SEC source: 0001415889-24-012937 · form4-05102024_090508.xml · nonDerivative · entry 1

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 234,495

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 10, 2024 Filed May 11, 2024 01:35 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 90 $107.48 $9,673.20
Disclosure

SEC source: 0001415889-24-012936 · form4-05102024_090506.xml · nonDerivative · entry 5

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 319,061

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

Read SEC document
May 10, 2024 Filed May 11, 2024 01:35 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 611 $106.32 $64,959.26
Disclosure

SEC source: 0001415889-24-012936 · form4-05102024_090506.xml · nonDerivative · entry 4

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 319,151

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.16 to $106.98 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 10, 2024 Filed May 11, 2024 01:35 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 660 $105.51 $69,636.01
Disclosure

SEC source: 0001415889-24-012936 · form4-05102024_090506.xml · nonDerivative · entry 3

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 319,762

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.86 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 10, 2024 Filed May 11, 2024 01:35 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 990 $104.60 $103,558.85
Disclosure

SEC source: 0001415889-24-012936 · form4-05102024_090506.xml · nonDerivative · entry 2

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 320,422

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.99 to $104.95 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 10, 2024 Filed May 11, 2024 01:35 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 349 $103.06 $35,966.93
Disclosure

SEC source: 0001415889-24-012936 · form4-05102024_090506.xml · nonDerivative · entry 1

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 321,412

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.87 to $103.57 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes 397 shares acquired under the Issuer's 2015 Employee Stock Purchase Plan on April 29, 2024.

Read SEC document
May 08, 2024 Filed May 11, 2024 01:35 UTC
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
Exercise / conversionStock Option (right to buy) · Derivative 215,000 $0.00 Strike: $5.40 $0.00
Disclosure

SEC source: 0001415889-24-012935 · form4-05102024_090501.xml · derivative · entry 3

Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 398,496

Underlying: Common Stock · 215,000 shares

Expires 2024-12-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option shares are fully exercisable.

Read SEC document
May 08, 2024 Filed May 11, 2024 01:35 UTC
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
Exercise / conversionCommon Stock 215,000 $5.40 $1,159,989.50
Disclosure

SEC source: 0001415889-24-012935 · form4-05102024_090501.xml · nonDerivative · entry 1

Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,290,648

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2024 Filed May 4, 2024 01:35 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 200 $95.64 $19,128.00
Disclosure

SEC source: 0001415889-24-012265 · form4-05032024_090501.xml · nonDerivative · entry 4

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,542

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.50 to $95.78 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 01, 2024 Filed May 4, 2024 01:35 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 400 $94.70 $37,879.00
Disclosure

SEC source: 0001415889-24-012265 · form4-05032024_090501.xml · nonDerivative · entry 3

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,742

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.39 to $94.96 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 01, 2024 Filed May 4, 2024 01:35 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 866 $93.88 $81,298.52
Disclosure

SEC source: 0001415889-24-012265 · form4-05032024_090501.xml · nonDerivative · entry 2

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 68,142

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.34 to $94.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 01, 2024 Filed May 4, 2024 01:35 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 400 $92.60 $37,038.00
Disclosure

SEC source: 0001415889-24-012265 · form4-05032024_090501.xml · nonDerivative · entry 1

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 69,008

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.20 to $93.05 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 29, 2024 Filed May 2, 2024 01:05 UTC
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
SaleCommon Stock 929 $93.14 $86,525.85
Disclosure

SEC source: 0001415889-24-011942 · form4-05012024_090510.xml · nonDerivative · entry 1

Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 110,748

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023.

Read SEC document
April 29, 2024 Filed May 2, 2024 01:05 UTC
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
SaleCommon Stock 1,196 $93.14 $111,393.89
Disclosure

SEC source: 0001415889-24-011943 · form4-05012024_090513.xml · nonDerivative · entry 1

Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,833

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023.

Read SEC document
April 29, 2024 Filed May 2, 2024 01:05 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
SaleCommon Stock 4,084 $93.14 $380,378.45
Disclosure

SEC source: 0001415889-24-011939 · form4-05012024_090503.xml · nonDerivative · entry 1

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 226,235

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023.

Read SEC document
April 29, 2024 Filed May 2, 2024 01:05 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 1,238 $93.14 $115,305.71
Disclosure

SEC source: 0001415889-24-011938 · form4-05012024_090501.xml · nonDerivative · entry 1

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 69,408

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023.

Read SEC document
April 29, 2024 Filed May 2, 2024 01:05 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
SaleCommon Stock 1,057 $93.14 $98,447.61
Disclosure

SEC source: 0001415889-24-011940 · form4-05012024_090505.xml · nonDerivative · entry 1

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 204,495

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023.

Read SEC document
April 26, 2024 Filed Apr 27, 2024 01:35 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 751 $92.00 $69,092.00
Disclosure

SEC source: 0001415889-24-011631 · form4-04262024_090401.xml · nonDerivative · entry 3

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,646

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023.

Read SEC document
April 26, 2024 Filed Apr 30, 2024 20:35 UTC
HEALY JAMESDirector
GrantCommon Stock 210 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-011830 · form4-04302024_080415.xml · nonDerivative · entry 1

HEALY JAMES · CIK 0001245624 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,710

F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $19,375 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
April 26, 2024 Filed May 1, 2024 00:35 UTC GrantCommon Stock 244 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-011826 · form4-04302024_080407.xml · nonDerivative · entry 2

ROSENMAN HERM · CIK 0001230057 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,417

F3 · shares: Represents the issuance of RSUs to the Reporting Person in lieu of quarterly retainer fees of $22,500 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
April 26, 2024 Filed May 1, 2024 00:35 UTC GrantCommon Stock 488 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-011826 · form4-04302024_080407.xml · nonDerivative · entry 1

ROSENMAN HERM · CIK 0001230057 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,173

F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over one year. 25% of the RSUs vest immediately and the remaining RSUs vest in three equal quarterly installments thereafter.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
April 26, 2024 Filed May 1, 2024 00:35 UTC
BOTHA ROELOFDirector
GrantCommon Stock 278 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-011825 · form4-04302024_080401.xml · nonDerivative · entry 2

BOTHA ROELOF · CIK 0001222287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,042

F3 · shares: Represents the issuance of RSUs to the Reporting Person in lieu of quarterly retainer fees of $25,625 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
April 26, 2024 Filed May 1, 2024 00:35 UTC
BOTHA ROELOFDirector
GrantCommon Stock 488 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-011825 · form4-04302024_080401.xml · nonDerivative · entry 1

BOTHA ROELOF · CIK 0001222287 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,764

F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over one year. 25% of the RSUs vest immediately and the remaining RSUs vest in three equal quarterly installments thereafter.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
April 26, 2024 Filed May 1, 2024 00:35 UTC GrantCommon Stock 169 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-011829 · form4-04302024_080413.xml · nonDerivative · entry 1

Baynes Roy D. · CIK 0001680739 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,576

F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $15,625 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
April 26, 2024 Filed May 1, 2024 00:35 UTC GrantCommon Stock 488 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-011828 · form4-04302024_080411.xml · nonDerivative · entry 1

Marcus Gail Boxer · CIK 0001702176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,634

F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over one year. 25% of the RSUs vest immediately and the remaining RSUs vest in three equal quarterly installments thereafter.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
April 26, 2024 Filed May 1, 2024 00:35 UTC GrantCommon Stock 488 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-011827 · form4-04302024_080409.xml · nonDerivative · entry 1

Chapman Rowan E · CIK 0001786240 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,861

F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over one year. 25% of the RSUs vest immediately and the remaining RSUs vest in three equal quarterly installments thereafter.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
April 25, 2024 Filed Apr 27, 2024 01:35 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 705 $89.55 $63,132.75
Disclosure

SEC source: 0001415889-24-011631 · form4-04262024_090401.xml · nonDerivative · entry 2

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,397

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023.

Read SEC document
April 25, 2024 Filed Apr 27, 2024 01:35 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 500 $89.55 $44,775.00
Disclosure

SEC source: 0001415889-24-011632 · form4-04262024_090404.xml · nonDerivative · entry 2

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Indirect · By Caraluna 2 Trust

Disclosed balance after: 69,082

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023.

F2 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.

Read SEC document
April 25, 2024 Filed Apr 27, 2024 01:35 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 500 $89.55 $44,775.00
Disclosure

SEC source: 0001415889-24-011632 · form4-04262024_090404.xml · nonDerivative · entry 1

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Indirect · By Caraluna 1 Trust

Disclosed balance after: 69,082

F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023.

F2 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.

Read SEC document
April 24, 2024 Filed Apr 27, 2024 01:35 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 937 $93.00 $87,140.16
Disclosure

SEC source: 0001415889-24-011631 · form4-04262024_090401.xml · nonDerivative · entry 1

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 72,102

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023.

Read SEC document
April 23, 2024 Filed Apr 24, 2024 01:35 UTC
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
SaleCommon Stock 522 $91.38 $47,699.94
Disclosure

SEC source: 0001415889-24-011404 · form4-04232024_090411.xml · nonDerivative · entry 1

Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 111,677

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021 and January 28, 2022, respectively.

Read SEC document
April 23, 2024 Filed Apr 24, 2024 01:35 UTC
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
SaleCommon Stock 531 $91.38 $48,522.36
Disclosure

SEC source: 0001415889-24-011405 · form4-04232024_090418.xml · nonDerivative · entry 1

Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 117,029

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 22, 2021 and January 28, 2022, respectively.

Read SEC document
April 23, 2024 Filed Apr 24, 2024 01:35 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
SaleCommon Stock 2,552 $91.38 $233,199.72
Disclosure

SEC source: 0001415889-24-011403 · form4-04232024_090405.xml · nonDerivative · entry 3

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 230,319

F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021 and January 28, 2022.

Read SEC document
April 23, 2024 Filed Apr 24, 2024 01:35 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 1,523 $91.38 $139,170.52
Disclosure

SEC source: 0001415889-24-011402 · form4-04232024_090401.xml · nonDerivative · entry 4

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,039

F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, October 22, 2021, and January 28, 2022.

Read SEC document
April 23, 2024 Filed Apr 24, 2024 01:35 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
SaleCommon Stock 787 $91.38 $71,915.43
Disclosure

SEC source: 0001415889-24-011406 · form4-04232024_090420.xml · nonDerivative · entry 3

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 205,552

F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021 and January 28, 2022.

Read SEC document
April 22, 2024 Filed Apr 24, 2024 01:35 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 1,250 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-011402 · form4-04232024_090401.xml · derivative · entry 7

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 1,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on October 22, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.

F5 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on October 22, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.

Read SEC document
April 22, 2024 Filed Apr 24, 2024 01:35 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 1,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-011402 · form4-04232024_090401.xml · nonDerivative · entry 3

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,562

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
April 21, 2024 Filed Apr 24, 2024 01:35 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
Exercise / conversionRestricted Stock Unit · Derivative 1,775 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-011403 · form4-04232024_090405.xml · derivative · entry 5

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,324

Underlying: Common Stock · 1,775 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.

F4 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.

Read SEC document
April 21, 2024 Filed Apr 24, 2024 01:35 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
Exercise / conversionCommon Stock 1,775 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-011403 · form4-04232024_090405.xml · nonDerivative · entry 2

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 232,871

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.